The following is a summary of the National Research Corporation (NRC) Q1 2024 Earnings Call Transcript:

Financial Performance:

• National Research Corporation's financial results for Q1 2024 were consistent with expectations and showed no significant year-over-year changes.

• The company's net debt stands at approximately $40 million.

• They have a robust financial capacity with $23 million available on their line of credit and another $56 million available under the delayed draw term loan facility.

• There was a marked increase in Operating cash flows to $12 million, up from $8 million the previous year.

Business Progress:

• National Research Corporation is focused on doubling its total addressable market through portfolio additions, acquisitions, and partnerships.

• They envision driving double-digit annual revenue growth, enhancing margins, and providing substantial value to investors.

• They plan to introduce AI-enhanced, healthcare-specific solutions later this year.

• The expansion of their sales force is in the pipeline, with significant hiring expected over the coming two to three years.

• Organizational changes have been enacted, with new leadership roles, sales associates, and a technology team restructure.

• They have shown a commitment to investment and shareholder value, spending $4 million on innovation and growth and returning $18 million to stockholders through dividends and stock repurchases.

More details: National Research IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.